Abstract
Molybdenum cofactor deficiency classically presents in neonates with intractable seizures; however, milder cases generally present before age 2 years with developmental delays and may go undiagnosed. Early diagnosis, and safe, US Food and Drug Administration-approved substrate replacement are critical to preserve neurologic function. This article discusses 2 children who presented with late-onset molybdenum cofactor deficiency type A.
Originalsprog | Engelsk |
---|---|
Artikelnummer | e2023062548 |
Tidsskrift | Pediatrics |
Vol/bind | 153 |
Udgave nummer | 6 |
Antal sider | 7 |
ISSN | 0031-4005 |
DOI | |
Status | Udgivet - 2024 |